Introduction
============

In plants, *de novo* biosynthesis of fatty acids occurs exclusively in chloroplasts. The fatty acids generated are either directly metabolized into glycolipids and PG within the chloroplast or exported across the envelope to the ER to form phospholipids and neutral lipids. To synthesize these glycerolipids in both chloroplast and ER, glycerol-3-phosphate acyltransferase (GPAT, E.C. 2.3.1.15) is first required to acylate fatty acids in the glycerol backbone of G-3-P. This enzyme localized in ER was demonstrated to be crucial for cutin, suberin, or storage oil biosynthesis in *Arabidopsis* *thaliana* ([@B64]; [@B20]), *Ricinus* *communis* ([@B7]) and *Brassica* *napus* ([@B9]). In addition, it was found that a deficiency in the chloroplastidial GPAT activity could cause a reduction (10--25%) in the PG content of *Arabidopsis* ([@B27]; [@B60]). Thus, GPAT has been found to play a pivotal role in initiating all glycerolipid biosynthesis in higher plants. In comparison, functional analyses of GPAT from microalgae are rare.

To understand the features of the first step of glycerolipid biosynthesis catalyzed by GPAT in microalgae, we attempted to identify one cloned GPAT gene from an oleaginous green microalga, *Lobosphaera incisa* Reisigl (designated as LiGPAT). This microalga possesses a high content of photosynthetic membrane lipids as suggested by a large incised chloroplast with many parallel thylakoid membranes ([@B33]; [@B37], [@B38]), and it has the ability to accumulate TAG to form oil bodies in cells, especially under nitrogen starvation ([@B26]; [@B63]; [@B52]; [@B38]). Thus, the study of the function of the GPAT gene from *L*. *incisa* might indicate the role of GPAT in microalgae. Given that GPAT in plants can localize to the chloroplast or the ER, the subcellular localization of the encoded protein LiGPAT was analyzed by bioinformatics technique. Heterologous complementation in a GPAT deficient mutant of yeast, *gat1*Δ ([@B65]), was used to validate the function of *LiGPAT*, and the yeast lipids were analyzed by lipidomic approaches using UPLC-ESI-Q-TOF-MS and multivariate data analysis. Surprisingly, we found that the conserved His in the G-3-P binding sites from chloroplastidial GPATs was substituted by Arg at position 195 in this chloroplastidial LiGPAT mature protein, and site-directed mutagenesis at this site of LiGPAT improved the phospholipid level in yeast. These findings help us to understand the characteristics of a putatively chloroplastidial GPAT in *L*. *incisa* and thus provide a strategy for genetic engineering to improve the microalgae-based production of biofuels.

Materials and Methods {#s1}
=====================

Strains, Medium and Growth Conditions
-------------------------------------

*Lobosphaera incisa*, deposited in the Culture Collection of Algae of Charles University in Prague under ID H4301 was cultivated in BG-11 medium ([@B48]) in 500-mL glass flasks as described previously ([@B38]). During culture, the flasks were shaken several times a day by hand at regular intervals.

Cloning of cDNA and DNA Encoding *LiGPAT*
-----------------------------------------

A pair of degenerate primers (G1 and G2) (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**) for the LiGPAT gene cDNA cloning were designed based on the amino acid sequences of GPAT from *Ostreococcus tauri* (GenBank Accession Number 116061306) and *Chlamydomonas reinhardtii* (GenBank Accession Number 159473711). Total RNA isolated by TRIzol reagent (Invitrogen) from *L*. *incisa* was used to synthesize cDNA with a Reverse Transcribed Kit II (TaKaRa). The full-length cDNA of *LiGPAT* was amplified by a SMART^TM^ RACE cDNA Amplification Kit (Clontech). Two gene-specific primers (NGSP5-1 and GSP5-2) for the first 5′-RACE reaction, one gene-specific primer (GSP5-4) for the second 5′-RACE reaction, and two gene-specific primers (NGSP3-1 and GSP3-2) for the 3′-RACE reaction were designed (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). Genomic DNA extracted by the CTAB method from *L*. *incisa* ([@B13]) was used to amplify both the coding region and the untranslated region of *LiGPAT* with four pairs of primers (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). All PCR products of the expected size were cloned into the pMD19-T cloning vector (TaKaRa). The resulting constructs were transformed into *Escherichia coli* DH5α and verified by sequencing. The BLAST Server^[2](#fn02){ref-type="fn"}^ was used to annotate the cloned sequences.

Southern Blot Analysis of *LiGPAT*
----------------------------------

Genomic DNA of *L*. *incisa* was double digested with *Xho*I/*Not*I or *Hind*III/*Not*I restriction endonucleases at 37°C for 4-6 h. The digested DNA samples were fractionated on a 1.0% agarose gel and then transferred to a NC filter membrane (Millipore). A pair of primers was designed based on the conserved domain of GPAT (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). A 311-bp biotin-labeled DNA sequence was prepared to use as a probe with a North2South^®^ Biotin Random Prime Labeling Kit (Thermo Scientific). Subsequently, the hybridization was detected by the standard Southern blot procedure ([@B43]) with a North2South Chemiluminescent Hybridization and Detection Kit (Thermo Scientific). Signals were visualized by exposure to XBT-1 film (Kodak) at room temperature for 60-120 s.

Bioinformatics Analysis
-----------------------

The intron and exon regions from *LiGPAT* were analyzed using Spidey^[3](#fn03){ref-type="fn"}^. Signal peptide sites of the amino acid sequence of LiGPAT were predicted by the SignalP 4.1 Server^[4](#fn04){ref-type="fn"}^, and the transit peptide sites were predicted by the TargetP 1.1 Server^[5](#fn05){ref-type="fn"}^ and the ChloroP 1.1 Server^[6](#fn06){ref-type="fn"}^. Conserved domains were searched in NCBI's CDD ([@B32]). The PredictProtein program^[7](#fn07){ref-type="fn"}^ was applied to predict protein structural and functional features ([@B41]). Protein structures were performed with I-TASSER^[8](#fn08){ref-type="fn"}^ ([@B42]). The superimposed images of the LiGPAT tertiary structure were obtained from SuperPose 1.0^[9](#fn09){ref-type="fn"}^ ([@B31]) and displayed with UCSF Chimera 1.10 ([@B39]).

Multiple Sequence Alignment of GPAT Homologs
--------------------------------------------

The available chloroplastidial GPAT amino acid sequences of *Arabidopsis thaliana* (GenBank Accession Number Q43307), *Auxenochlorella protothecoides* (GenBank Accession Number KFM22407), *Chlamydomonas reinhardtii* (GenBank Accession Number XP_001694977), *Coccomyxa subellipsoidea* C-169 (GenBank Accession Number XP_005643353), *Cucurbita moschata* (GenBank Accession Number BAB17755), *Cyanidioschyzon merolae* Strain 10D (GenBank Accession Number XP_006587606), *Glycine max* (GenBank Accession Number XP_006587606), *Micromonas pusilla* CCMP 1545 (GenBank Accession Number XP_003060587), *Micromonas* sp. RCC299 (GenBank Accession Number XP_002505030), *Ostreococcus lucimarinus* (GenBank Accession Number ABO94442), *Ostreococcus tauri* (GenBank Accession Number CAL52024), *Phaeodactylum tricornutum* (GenBank Accession Number XP_002184838), *Ricinus communis* (GenBank Accession Number XP_002518993), *Thalassiosira pseudonana* (GenBank Accession Number XP_002292905), and *Volvox carteri* f. *nagariensis* (GenBank Accession Number XP_002950506) were retrieved from GenBank. The amino acid sequences of the ER-bound GPAT isoform 4 (GenBank accession number Q9LMM0), isoform 5 (GenBank Accession Number NP_187750), isoform 6 (GenBank Accession Number NP_181346), and isoform 8 (GenBank Accession Number NP_191950) from *Arabidopsis thaliana*, and ER-bound GPAT from *Medicago truncatula* (GenBank Accession Number AES79440) and *Ricinus communis* (GenBank Accession Number XP_002511873) were also obtained from GenBank. Multiple sequence alignment of the chloroplastidial GPATs and the ER-bound GPATs were performed with the ClustalX program ([@B51]). The web-based BLAST2 program ([@B1]) at NCBI was employed to generate pairwise similarity scores of the aligned sequences. The Multiple EM for Motif Elicitation (MEME) program ([@B3]) was used to identify conserved sequence motifs.

Phylogeny Inference
-------------------

The amino acid sequences of GPAT as well as LPAAT from higher plants and microalgae were retrieved from GenBank. Three GPATs from *Nitrosococcus halophilus*, *Bradyrhizobium japonicum*, and *Ralstonia pickettii* DTP0602 were chosen as an arbitrary outgroup. All accession numbers are presented in the phylogeny tree. All of the conserved domain sequences annotated by searching CDD were also aligned with the ClustalX program ([@B51]). Phylogenetic analysis was conducted using maximum likelihood (ML) methods with MEGA 6.0 ([@B50]) by using the most appropriate model (LG + G + Γ) determined by ProtTest v3.3 ([@B12]). Branch points were tested for significance by bootstrapping with 1,000 replications ([@B16]; [@B50]).

Construction of *mLiGPAT* and *sdmLiGPAT* Expression Plasmids
-------------------------------------------------------------

To construct a bacterial plasmid, the 1,131-bp of the LiGPAT mature protein coding gene (designated as *mLiGPAT*) with *Bam*HI/*Xho*I digestion sites was amplified with a pair of primers (EcBamF and XhoR) (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). The PCR products were sticky-ended and subcloned into the *Bam*HI/*Xho*I sites of pET 28a to obtain the plasmid pET-mLiG.

For heterologous expression in yeast, *mLiGPAT* and the site-directed mutation (Arg195His) of *mLiGPAT* (designated as *sdmLiGPAT*) expression plasmids were constructed. An approximately 1.2 kb cDNA fragment containing the *Bam*HI/*Xho*I digestion sites of *mLiGPAT* was amplified with the primers ScBamF and XhoR (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). Site-directed mutagenesis by splicing overlap extension PCR (SOE-PCR) ([@B19]) was performed to generate *sdmLiGPAT* with *Bam*HI/*Xho*I digestion sites using four primers ScBamF, MuScR, XhoR, and MuScF (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). The PCR products of *mLiGPAT* and *sdmLiGPAT* were sticky-ended and subcloned into the *Bam*HI/*Xho*I sites of pYES2 (Invitrogen) to obtain the plasmids pY-mLiG and pY-sdmLiG, respectively. Prior to transforming the resulting plasmids into host cells, the correct orientation and in-frame fusion of all of the inserts was verified by sequencing.

Heterologous Expression of *LiGPAT*
-----------------------------------

To obtain soluble, recombinant mLiGPAT protein, the plasmid pET-mLiG and the vector pET 28a as a control were introduced into *E*. *coli* BL21 (DE3) pLysS (designated pmLiG/BL and pET/BL), respectively. Single colonies of pmLiG/BL or pET/BL were inoculated in LB medium. After incubation at 37°C for 12 h, the cells were collected and resuspended in LB medium with 1 mM IPTG to obtain an OD600 of 0.6. After incubation at 18°C overnight ([@B44]), soluble recombinant protein with a His-tag was expressed and detected by SDS-PAGE.

To express *mLiGPAT* and *sdmLiGPAT* in yeast for functional identification, we chose the GPAT deficient yeast mutant, *gat1*Δ (*BY4742*, *Matα*, *his3Δ1*, *leu2Δ0*, *lys2Δ0*, *ura3Δ0*, *YKR067w:*:*kanMX4*) as described by [@B65]. This strain was purchased from EUROSCARF^[10](#fn010){ref-type="fn"}^. Single colonies carrying pYES2 (plasmid-only as a control) or pY-mLiG or pY-sdmLiG (designated gPY, gmLiGPAT, and gsdmLiGPAT, respectively) were inoculated into SC-uracil medium with 2% glucose. The parental strain of *gat1*Δ, BY4742 (*Matα*, *his3Δ1*, *leu2Δ0*, *lys2Δ0*, *ura3Δ0*), was used as a positive control, while *gat1*Δ was used as a negative control. After incubation at 30°C for 30 h, cells of *gat1*Δ, gPY, BY4742, gmLiGPAT, and gsdmLiGPAT were collected by centrifugation and resuspended in SC-uracil medium with 2% galactose. After incubation at 30°C for 12 h to reach to the logarithmic phase, the yeast cells were transferred to 16°C and incubated for another 48 h. Cells were harvested by centrifugation at 4°C. For preparation of the yeast homogenates, the cell pellets were washed with 10 volumes of distilled H~2~O and then immediately frozen in liquid nitrogen and stored at -80°C until use. For total lipid extraction, the cell pellets were lyophilized and stored at -20°C until use. Each sample was collected in duplicate. Colony PCR of each sample was accomplished using the primers pYF and pYR (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**) to ensure the insertion of the target gene.

Polyclonal Antibody Preparation and Purification
------------------------------------------------

Soluble recombinant mLiGPAT protein was purified by Ni-affinity column chromatography (Bio-Rad) and verified by HPLC-MS. New Zealand rabbits were immunized for LiGPAT polyclonal antibody preparation. The purified mLiGPAT protein was electrophoretically transferred from SDS polyacrylamide gels to NC membranes (Millipore) for polyclonal antibody preparation ([@B47]). Next, the NC blots were incubated for l h in 3% BSA in PBS before an additional incubation in the prepared LiGPAT polyclonal antibody for 16 h at 4°C. Afterward, the blots were washed several times with PBS and eluted with 0.2 M glycine-HCl (pH 2.3) for 20 min. The eluate was immediately neutralized by the addition of 1 M Tris-HCl and PBS and stored at -20°C until use.

Western Blot Analysis
---------------------

Fresh cells of *L*. *incisa* were ground in liquid nitrogen, resuspended in 50-100 μL breaking buffer (25 mM Tris-HCl, pH 6.5, 50 mM NaCl, 2 mM β-mercaptoethanol) and vortexed. Frozen cell pellets of yeast were resuspended in 500 μL breaking buffer (50 mM PBS, pH 7.4, 1 mM EDTA, 5% glycerol, 1 mM PMSF) and lysed by shear force using acid-washed glass beads according to the user manual (Invitrogen). Frozen cell pellets of *E*. *coli* were resuspended in 0.1 M PBS buffer and then sonicated on ice with a probe sonicator until the suspension was partially clear.

The lysed cells were centrifuged at 20,000 × *g* at 4°C, and the supernatant was collected and stored at -80°C until use. The protein concentration was determined by the Bradford protein assay ([@B6]).

Crude proteins from *L*. *incisa*, *E*. *coli* or yeast were electrophoretically transferred to NC membranes (Millipore) as described above, and the Western blots were performed according to the standard protocol ([@B43]). The purified LiGPAT polyclonal antibody and the secondary antibody, peroxidase-conjugated goat anti-rabbit IgG (Shanghai Youke Biotechnology Co., Ltd.), were appropriately diluted. Immunoreactive bands were visualized by the addition of DAB according to the manufacturer's manual (Tiangen). The levels of mLiGPAT and sdmLiGPAT expressed in yeast were semi-quantified by measuring the band intensity on their corresponding blots with ImageJ software^[11](#fn011){ref-type="fn"}^.

Total Lipid Extraction and Fractionation
----------------------------------------

Total lipid from yeast was extracted according to [@B5] with minor modifications. Acid washed glass beads with a diameter of 0.4-0.6 mm (Omega Bio-Tek) were used to break the cell walls. The extent of lysis was observed with a microscope, keeping the degree of breakage of each sample the same as far as possible.

Phospholipids from the extracted total lipids of approximately 50 mg lyophilized yeast were separated using solid-phase extraction ([@B10]). A 500 mg cartridge of silica gel (CNW) was first conditioned by elution with 5 mL of chloroform, and the total lipids from yeast were then applied to it. Elution with 10 mL of methanol yielded the phospholipids. This fraction was concentrated under a stream of nitrogen gas and then weighed.

UPLC-ESI-Q-TOF-MS Analysis
--------------------------

Reversed-phase analysis of lipids was performed on a Waters ACQUITY UPLC system using an ACQUITY UPLC BEH C8 analytical column (i.d. 2.1 × 100 mm, particle size 1.7 μm). The temperature of the sample chamber was set at 4°C, the column temperature was set at 40°C, and the injection volume was 4 μL for each analysis. A 1:4 split of the column effluent was used to achieve a flow rate of approximately 0.35 mL/min into the ESI source. To produce ions that could be readily fragmented, 0.001% lithium acetate and 0.1% formic acid were added to the mobile phase as the electrolyte. For efficient separation of the total lipids, water/tetrahydrofuran (3:1, v/v) was used as the mobile phase A and acetonitrile/methanol/tetrahydrofuran (2:1:1, v/v/v) as the mobile phase B. The initial composition of the mobile phase B was changed from 40 to 70% in 10 min and held for 7 min, then increased to 100% in 6 min and held for 1 min, and finally returned to the initial 40% in 1 min and equilibrated for 10 min. MS analysis was performed in a negative ion mode on a Waters Q-TOF Premier mass spectrometer. The mass range was from 100 to 1,200 with a scan duration of 0.3 s and an interscan delay of 0.02 s. High-purity nitrogen was used as the nebulizer and drying gas at a constant flow rate of 50 L/h, and the source temperature was set at 120°C. The capillary voltage was set at 2.6 kV, and the sampling cone voltage was set at the ramp of 35--80 V. MS/MS analysis was performed at a collision energy range of 25-35 V with argon as the collision gas. The TOF analyzer was used in a V mode and tuned for maximum resolution (\>10,000 resolving power at m/z 1,000). Prior to the experiment, the instrument was calibrated with sodium formate, and the lock mass spray for precise mass determination was set with leucine enkephalin at a concentration 400 ng/μL, generating an \[M-H\]^-^ ion at 554.2615 Da in ESI^-^ mode. The lock spray frequency was set at 10 s.

Lipidomics Data Processing
--------------------------

The original data from the ESI^-^ mode were acquired by the UPLC-Q-TOF-MS system and analyzed by a MassLynx 4.1 data processing system (Waters). The MarkerLynx matrices with peak numbers \[based on the RT and mass-to-charge ratio (m/z)\], sample names, and normalized peak intensities were exported to SIMCA-P+ 12.0 (Umetrics) and analyzed by PCA, PLS-DA, and OPLS-DA. The quality of the models PLS-DA and OPLS-DA was evaluated by two parameters, R^2^Y(cum) and Q^2^(cum). R^2^Y(cum) is the cumulative fraction of the sum of squares of all Y-variables that the model can explain using the latent variables, indicating the explanative ability of the model. Q^2^(cum) depicts the cumulative fraction of the total variation that can be predicted using the model via sevenfold cross-validation, indicating the predictability of the model. In general, R^2^Y(cum) and Q^2^(cum) values close to 1.0 indicate an excellent fit to the model, and the difference between these two values should be less than 0.3 ([@B58]). If the value of the Q^2^(cum) is higher than 0.9, the model is considered an excellent one ([@B58]). CV-ANOVA was systematically performed based on the PLS-DA model to rule out the non-randomness of the separation between groups. Generally, in permutation tests with 999 iterations, the intercept value of *Q*^2^ \> 0.05 indicates over-fit in the original model ([@B25]; [@B29]).

Identification of Lipid Metabolites
-----------------------------------

Variables meeting two criteria, specifically, high VIP and CIJF~JK~ excluding zero, were selected as potential lipid biomarkers, which contributed to the separation between groups ([@B14]; [@B8]). The lipid metabolites were identified by the RT, m/z, and the characteristic fragment ions deduced by MS/MS ([@B61]). In addition, some public databases including HMDB^[12](#fn012){ref-type="fn"}^, LIPID MAPS^[13](#fn013){ref-type="fn"}^, and METLIN^[14](#fn014){ref-type="fn"}^ were also used to help elucidate the putative ion structures.

Results
=======

Cloning and Characterization of the LiGPAT Gene
-----------------------------------------------

Based on the amino acid sequences of GPAT proteins available from *Ostreococcus tauri* and *Chlamydononas reinhardtii*, a pair of degenerate primers (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**) was designed, with which a 321-bp cDNA fragment was amplified from *L*. *incisa*. BLAST analysis revealed that this sequence was a GPAT homolog, and so it was designated *LiGPAT*. Subsequently, a 3,278-bp full-length cDNA of this gene, consisting of a 1,305-bp ORF, a 1,619-bp 5′-UTR, and a 354-bp 3′-UTR was obtained by the RACE technique. The nucleotide sequence of *LiGPAT* was identical to the unique annotated GPAT gene from the transcriptome of *L*. *incisa* ([@B36]). A comparison of the cDNA sequence with its corresponding DNA sequence (**Supplementary Figure [S1A](#SM2){ref-type="supplementary-material"}**) revealed that the gene contained seven introns. The introns, 279, 371, 404, 145, 307, 211, and 745 bp beginning from the 5′-end, contained splice sites that all conformed to the GT-AG rule. Both the cDNA and the DNA sequences of *LiGPAT* were deposited in GenBank under the accession numbers KM670441 and KM670442, respectively. Southern blot analysis of the genomic DNA digested by either *Not*I/*Xho*I or *Not*I/*Hind*III using a 311-bp specific probe suggested that *LiGPAT* was a single copy gene in *L*. *incisa* (**Supplementary Figure [S1B](#SM2){ref-type="supplementary-material"}**). The same result for nucleus-encoded chloroplastidial GPAT genes was observed in a number of angiosperm families ([@B23]; [@B27]; [@B56]; [@B35]; [@B4]).

The ORF of *LiGPAT* encoded a 434-amino acid peptide, in which the domains GPAT_N (GenBank Accession Number cl20739) and LPLAT_GPAT (GenBank Accession Number cd07985) were annotated by searching CDD. A structural motif similar to a prokaryotic membrane lipoprotein lipid attachment site (Leu^8^- Cys^18^) was identified by the PredictProtein program (**Figure [1A](#F1){ref-type="fig"}**). This motif was also identified in a chloroplastidial form of the acetyl-CoA carboxylase of pea ([@B45]) and a chloroplastidial NEF1 of *Arabidopsis thaliana* ([@B2]). Neither the transmembrane domain nor the signal peptide in LiGPAT was predicted, whereas the N-terminal sequence of 63 residues was identified as a cTP (**Figure [1A](#F1){ref-type="fig"}**) as predicted by both the TargetP 1.1 Server and the ChloroP 1.1 Server. Characteristics of this cTP, including a high content (14.28%) of hydroxylated residues (Ser and Thr), a high content (19.05%) of hydrophobic residues (Ala and Val), the absence of the acidic residues (Asp and Glu), and very few Pro and Gly among the first 10 residues, were consistent with previously described cTP sequences ([@B55]). These results suggested that the LiGPAT might be a chloroplastidial GPAT.

![**Multiple sequence alignment and phylogeny analysis of GPAT homologs.** Identical amino acids are indicated by "^∗^", and the important catalytic sites are boxed. **(A)** ClustalW alignment of the N-terminal sequences and four acyltransferase domain sequences from chloroplastidial GPATs. The identified GPAT_N domain is indicated by a dashed line box. The secondary structure assigned for the GPAT_N domain is represented by a cylinder (α-helix). A filled down arrow (▼) indicates the cleavage site of LiGPAT. The putative prokaryotic membrane lipoprotein lipid attachment site is indicated above the aligned sequences. Motifs I-IV were predicted by the MEME program. **(B)** ClustalW alignment of four acyltransferase domain sequences from ER-bound GPATs. Blocks I-IV were suggested by [@B28]. **(C)** Phylogeny inference based on GPAT and LPAAT amino acid sequences. The phylogeny tree was inferred by the Maximum Likelihood (ML) method based on LG + G + Γ. The tree with the highest log likelihood (-6,958.7325) is shown. Bootstrap analysis was based on 1,000 re-samplings, and only support values higher than 60% are shown in the phylogeny. All accession numbers are presented in the phylogeny tree.](fpls-07-00286-g001){#F1}

Alignment and Phylogeny Analysis of GPAT Homologs
-------------------------------------------------

To ascertain the features of chloroplastidial GPAT amino acid sequences, a pairwise sequence alignment and a complete multiple sequence alignment were carried out separately. The results of the pairwise alignment showed a higher similarity among chloroplastidial GPAT proteins from higher plant species (67-74%) than from microalgal species (33-79%). LiGPAT was more conserved with GPATs from other Trebouxiophyceae species (*Coccomyxa subellipsoidea* and *Auxenochlorella protothecoides*) and Chlorophyceae species (*Chlamydomonas reinhardtii* and *Volvox carteri*) (56-60%) than with Mamiellophyceae species (*Ostreococcus lucimarinus*, *Ostreococcus tauri*, *Micromonas pusilla*, and *Micromonas* sp.) (42-43%), Stramenopiles species (*Thalassiosira pseudonana* and *Phaeodactylum tricornutum*) (36-43%), and Rhodophyta species (*Cyanidioschyzon merolae*) (33%).

The complete multiple sequence alignment identified 39 fully conserved residues that corresponded to only 8.8% of the average 430 residues. The GPAT_N domain identified in LiGPAT was also found in GPATs from *Coccomyxa subellipsoidea*, *Chlamydomonas reinhardtii*, *Volvox carteri*, *Auxenochlorella protothecoides*, *Cucurbita moschata*, *Glycine max*, *Ricinus communis*, and *Arabidopsis thaliana* (**Figure [1A](#F1){ref-type="fig"}**). The length of the domain GPAT_N was similar (74-78 amino acid residues) except for that from *Auxenochlorella protothecoides*, due to the incomplete sequence, but its sequence was different from others (**Figure [1A](#F1){ref-type="fig"}**). In contrast, four motifs predicted by using the MEME program were relatively conserved (**Figure [1A](#F1){ref-type="fig"}**). The H(X)~4~D motif in Motif I was a conserved consensus sequence among many glycerolipid acyltransferases. The residues Lys, His, Arg, and Arg in Motif III and IV in chloroplastidial GPATs (**Figure [1A](#F1){ref-type="fig"}**) were considered to form a positive pocket to bind the phosphate group of G-3-P ([@B28]; [@B53]). It is worth noting that these four G-3-P binding sites were well conserved except for the His residue, which was replaced by Arg in *L*. *incisa* and *Coccomyxa subellipsoidea* (**Figure [1A](#F1){ref-type="fig"}**).

The ER-bound GPATs were aligned, and four acyltransferase domains were identified (**Figure [1B](#F1){ref-type="fig"}**). Interestingly, these acyltransferase domains were significantly different from those of chloroplastidial GPATs, except the His and Asp residues from the H(X)~4~D motif in Block I (**Figure [1B](#F1){ref-type="fig"}**). The Gly residue in Block III and the Pro residue in Block IV, both of which were suggested to be catalytically important sites ([@B28]), were completely conserved (**Figure [1B](#F1){ref-type="fig"}**). In addition, the residues Arg in Block II and Glu and Ser in Block III were invariant among the cytoplasmic GPATs for G-3-P binding (**Figure [1B](#F1){ref-type="fig"}**).

Although the previously defined conserved domains of GPAT were similar to those of LPAAT ([@B21]; [@B28]; [@B46]), the phylogenetic tree showed an apparently different phylogenetic support between lineages of GPAT and LPAAT except that the GPAT isoform 9 from *Arabidopsis thaliana* was in the LPAAT clade (**Figure [1C](#F1){ref-type="fig"}**). The ER-bound GPATs and the mitochondrial GPATs formed a cluster apart from the chloroplastidial one comprising both higher plants and microalgae (**Figure [1C](#F1){ref-type="fig"}**), and this result was in agreement with a previous report ([@B7]). This separation could be explained by the differences in the G-3-P binding and catalytically important sites between the cytoplasmic and the chloroplastidial GPATs as mentioned above. The phylogeny also suggested a sister group relationship between the subclade, consisting of diatoms and red algae, and the one comprising higher plants and green microalgae (**Figure [1C](#F1){ref-type="fig"}**), which was consistent with the sequence similarity among these species.

These multiple-sequence alignments and phylogeny indicated that LiGPAT possessed the sequence features that conformed to those of chloroplastidial GPATs, providing further evidence that LiGPAT was localized in *L*. *incisa* chloroplasts.

Functional Identification of *LiGPAT* in a *gat1*Δ Mutant of Yeast
------------------------------------------------------------------

Multiple sequence alignment (**Figure [1A](#F1){ref-type="fig"}**) showed that the Arg^195^ in mLiGPAT was different from His, which was considered one of the G-3-P binding sites in most chloroplastidial GPATs. When this residue His was mutated to Ser, the biological activity of squash chloroplastidial GPAT decreased ([@B46]). Accordingly, it was inferred that the catalytic ability of this LiGPAT might be different from (probably lower than) the one with His at position 195. Thus, to identify the function of *LiGPAT*, heterologous expression of *mLiGPAT* as well as its mutant (Arg195His) *sdmLiGPAT* generated by site-directed mutagenesis was performed in the GPAT-deficient yeast strain *gat1*Δ.

To identify the function of GPAT in yeast, the activity of this enzyme was determined *in vitro*, for example, by routinely using ^14^C-labeled G-3-P as described by [@B65]. Because of the inconvenience in other ordinary laboratories without any protection from irradiation, a metabolomics approach by using UPLC-ESI-Q-TOF-MS and multivariate data analysis ([@B17]; [@B59]; [@B54]) was employed in this study.

A PCA model with two-components was constructed, which showed that gsdmLiGPAT (site-directed mutated) clustered with the parental yeast strain BY4742 (this group was designated as the wild-type) but was clearly separated from the *gat1*Δ (GPAT-deficient) and plasmid-only control yeast gPY (this group was designated as deficient) (**Figure [2A](#F2){ref-type="fig"}**). In this PCA model, which could not be well validated, gmLiGPAT (mLiGPAT-transformed) did not significantly separate from the deficient group. In comparison, both the OPLS-DA \[*R^2^Y(cum)* = 0.992 and *Q^2^(cum)* = 0.964\] and the PLS-DA \[*R^2^Y(cum)* = 0.961 and *Q^2^(cum)* = 0.922\] models with high *R^2^Y(cum)* and *Q^2^(cum)* values could provide reliable support for the separation of gmLiGPAT and the wild-type group from the deficient group (**Figures [2B,C](#F2){ref-type="fig"}**). Validation of the PLS-DA model with the number of permutations equaling 999 generated intercepts of *R*^2^ = 0.54 and *Q*^2^ = -0.112 (**Figure [2D](#F2){ref-type="fig"}**), giving an additional proof of the statistically valid and well fit model because the intercept of Q^2^-point regression line was below zero. These statistical analyses indicated that lipid compositions of gmLiGPAT and gsdmLiGPAT indeed significantly differed from those of *gat1*Δ and gPY but were similar to those of the parental strain BY4742. It was concluded that the deficiency of GPAT in the mutant *gat1*Δ was corrected by the introduction of *LiGPAT*, thus confirming the acylation function of the GPAT protein from *L*. *incisa*.

![**Multivariate data analysis of lipidomics data from transgenic (gPY, gmLiGPAT, and gsdmLiGPAT), GPAT-deficient (*gat1*Δ), and parental (BY4742) yeasts in negative ion scan mode.** **(A)** PCA score plot of data from *gat1*Δ, gPY, gmLiGPAT, gsdmLiGPAT, and BY4742 for the first two components. **(B)** OPLS-DA score plot of data from the wild-type group (gmLiGPAT, gsdmLiGPAT, and BY4742) versus the deficient group (gPY and *gat1*Δ). **(C)** PLS-DA score plot of data from the wild-type group versus the deficient group. **(D)** Validation plot of PLS-DA analysis with the number of permutations equaling 999. *R*^2^ (filled triangle) is the explained variance, and *Q*^2^ (filled square) is an estimate of the predictive ability of the 7 models.](fpls-07-00286-g002){#F2}

To understand which lipid mainly contributed to the separation of the wild-type group from the deficient group, 35 potential lipid biomarkers (VIP ranged from 38.34 to 2.59 with an average of 7.80) (**Table [1](#T1){ref-type="table"}**) were selected according to both VIP values and the corresponding 95% confidence interval based on a jack-knife procedure ([@B14]). A total of 29 of these selected biomarkers were subsequently identified to be (PI, lyso-PI, PG, PS, PC, and PE (**Table [1](#T1){ref-type="table"}**). Among these metabolites, PI accounted for 55.17% (16--29) and possessed relatively high VIP (ranging from 2.83 to 38.34 with an average of 9.613) (**Table [1](#T1){ref-type="table"}**), indicating that this phospholipid was the main contributor to the separation. The relative abundance of most PI species from the wild-type group was higher than from the deficient group (**Figure [3](#F3){ref-type="fig"}**). This result was roughly consistent with the previous report ([@B40]) that the main increase of PI was observed when the yeast strain was cultured under low temperature. Therefore, the total relative abundance of PI species in the wild-type was compared with that in the deficient group. All of the PI species, 21 in total, were subsequently identified (**Table [2](#T2){ref-type="table"}**), and the relative abundance was compared. The results showed that the total relative abundance of PI from gmLiGPAT was higher, although not significantly higher (*P* \> 0.05), than from *gat1*Δ and gPY, whereas the total relative abundance of PI from gsdmLiGPAT was significantly higher (*P* \< 0.01) than from gmLiGPAT, *gat1*Δ, and gPY, but there was no significant difference (*P* \> 0.05) from BY4742 (**Figure [4C](#F4){ref-type="fig"}**). It was thus predicted that the site-directed mutagenesis of LiGPAT Arg195His might enhance the catalytic activity of this protein and result in an increase in the phospholipid level in yeast. The subsequent measurement of phospholipid content showed that the phospholipid level from gsdmLiGPAT was higher than from gmLiGPAT or BY4742 (**Figure [4D](#F4){ref-type="fig"}**), thus supporting the prediction.

###### 

Identification of the top 35 metabolites contributing to differences between the wild-type group (gmLiGPAT, gsdmLiGPAT, and BY4742) and the deficient group (*gat1*Δ and gPY).

  No   RT      m/z         VIP       Identification
  ---- ------- ----------- --------- -----------------
  1    11.11   835.5368    38.3386   18:1/16:0-PI
  2    10.09   807.5041    27.1032   16:0/16:1-PI
  3    6.82    339.2300    20.1118   Unknown
  4    6.82    163.1099    16.6411   Unknown
  5    10.30   807.5040    14.8547   16:1/16:0-PI
  6    10.98   719.4896    11.6084   16:0/16:1-PG
  7    9.97    781.4892    11.0091   12:0/18:0-PI
  8    10.16   781.4890    8.2496    18:0/12:0-PI
  9    10.72   833.5218    8.22112   18:1/16:1-PI
  10   3.96    299.2570    8.06764   16:1/16:1-PE
  11   11.66   835.5358    8.06364   18:0/16:1-PI
  12   13.44   863.5690    6.98515   18:1/18:0-PI
  13   11.04   821.5210    6.50701   16:0/17:1-PI
  14   11.23   686.4771    5.83435   16:1/16:1-PE
  15   10.98   745.5063    5.28594   18:1/16:1-PG
  16   9.97    717.4710    5.25232   16:1/16:1-PG
  17   10.16   717.4707    5.1447    16:1/16:1-PG
  18   13.96   760.5160    5.11763   18:1/16:0-PS
  19   13.63   760.5144    5.00298   16:0/18:1-PS
  20   12.45   688.4934    4.12377   16:0/16:1-PE
  21   2.80    271.2242    4.03169   Unknown
  22   13.27   863.5690    4.02396   18:1/18:0-PI
  23   9.33    753.4565    3.96868   16:0/12:0-PI
  24   11.02   807.5054    3.78887   16:1/16:0-PI or
                                     14:1/18:0-PI
  25   4.60    353.2115    3.77584   Unknown
  26   10.84   774.5312    3.75723   18:1/17:0-PS
  27   19.04   1114.7429   3.68253   Unknown
  28   11.36   833.5210    3.52542   16:1/18:1-PI
  29   12.85   714.5086    3.37159   16:1/18:1-PE
  30   12.06   835.5378    3.33699   16:0/18:1-PI
  31   21.81   710.6666    3.1069    Unknown
  32   10.00   793.4881    3.02204   16:0/15:1-PI
  33   9.63    805.4902    2.82583   16:1/16:1-PI
  34   10.14   722.4961    2.74706   12:0/16:0-PC
  35   3.35    478.2912    2.59477   18:1-lysoPE
                                     

![**Relative abundance of PI species in the top 35 VIP from *gat1*Δ, gPY, gmLiGPAT, gsdmLiGPAT, and BY4742**.](fpls-07-00286-g003){#F3}

###### 

List of identified PI species in the ESI^-^ model.

  No   RT      m/z        Identification
  ---- ------- ---------- -----------------
  1    6.72    723.4066   16:1/10:0-PI
  2    7.68    725.4233   16:0/10:0-PI
  3    9.32    753.4564   16:0/12:0-PI
  4    9.00    753.4598   12:0/16:0-PI
  5    9.57    779.4742   14:1/16:0-PI or
                          14:0-16:1-PI or
                          12:0/18:1-PI
  6    10.15   781.4889   18:0/12:0-PI
  7    9.97    781.4892   12:0/18:0-PI
  8    10.00   793.4881   16:0/15:1-PI
  9    9.61    805.4915   16:1/16:1-PI
  10   10.30   807.504    16:1/16:0-PI
       10.21   807.5042   
       10.58   807.5052   
       11.01   807.5056   
  11   10.09   807.5059   16:0/16:1-PI
  12   10.14   819.5068   16:1/17:1-PI
  13   11.03   821.5215   16:0/17:1-PI
  14   11.35   833.5210   16:1/18:1-PI
  15   10.70   833.5219   18:1/16:1-PI
  16   11.66   835.5358   18:0/16:1-PI
  17   11.11   835.5367   18:1/16:0-PI
  18   12.06   835.5378   16:0/18:1-PI
  19   12.47   861.5568   18:1/18:1-PI
  20   13.43   863.5687   18:1/18:0-PI
       13.27   863.5690   
  21   10.01   875.4960   16:0/21:2-PI
                          

![**The effect of site-directed mutagenesis of LiGPAT from Arg^195^ to His in yeast.** **(A)** Western blot analysis of gmLiGPAT and gsdmLiGPAT with the LiGPAT antibody. **(B)** The density of the blots of gmLiGPAT and gsdmLiGPAT were measured with ImageJ software and expressed in arbitrary optical density units. Values are the mean ± SD, *n* = 3. The average levels of gmLiGPAT and gsdmLiGPAT showed no difference (*P* \> 0.05). **(C)** Comparison of the total relative abundance of all PI species among *gat1*Δ, gPY, gmLiGPAT, gsdmLiGPAT, and BY4742. Values with the same letter showed no significant difference (*P* \> 0.05); the others showed significant differences (*P* \< 0.01). **(D)** Comparison of the concentration of phospholipids among *gat1*Δ, gPY, gmLiGPAT, gsdmLiGPAT, and BY4742. Values with the same letter showed no significant difference (*P* \> 0.05); the others showed significant differences (*P* \< 0.05).](fpls-07-00286-g004){#F4}

Discussion
==========

Plastid-Localized GPAT from *L*. *incisa*
-----------------------------------------

Glycerol-3-phosphate acyltransferases targeting the chloroplast, cytoplasm, and mitochondrion have been recognized in plants. The chloroplastidial GPAT localized in the stroma is a soluble protein, and it can utilize acyl-(acyl-carrier protein) as the acyl donor ([@B24]). In contrast, the cytoplasmic form targeted to the ER is hydrophobic, and it is able to utilize acyl-CoA as the acyl donor ([@B18]). Genes of both chloroplastidial and ER-bound GPAT from several higher plants have been cloned, a total of 10 from *Arabidopsis* ([@B64]; [@B60]; [@B20]; [@B7]; [@B9]; [@B62]), 9 from *Ricinus communis* ([@B7]), and at least 2 from *Glycine max* ([@B15]), for instance. Examination of the algal genomes indicated that the microalgae *Chlamydomonas reinhardtii*, *Ostreococcus tauri*, *Cyanidioschyzon merolae* strain 10D, *Phaeodactylum tricornutum* CCAP 1055/1, and *Thalassiosira pseudonana* CCMP1335 were missing the recognizable extraplastidial GPAT homologs ([@B30]). It was suggested that the GPATs in these microalgae might have dual localization in both chloroplast and ER ([@B30]).

The present study provides the convincible bioinformatics evidence that one GPAT from the green microalga *L*. *incisa* is localized to chloroplasts (**Figures [1A,C](#F1){ref-type="fig"}**). In the latest NCBI database, there were deposited putative green microalgal GPATs, which were similar to the ER-bound GPAT9 from *Arabidopsis*. Therefore, it was inferred that the GPATs from *L*. *incisa* and the above-mentioned microalgae might be only localized to chloroplasts. Obviously, this idea would be more convincing and significant with analysis of accurate subcellular localization of the chloroplastidial GPATs and function of the cytoplasmic ones from these green microalgae.

Site-Directed Mutagenesis of LiGPAT Resulted in an Increase of the Phospholipid Level in Yeast
----------------------------------------------------------------------------------------------

The phospholipid level of the yeast transformed with the site-directed mutated *LiGPAT* (Arg195His) was higher than that of yeast transformed with the original *LiGPAT* (**Figure [4D](#F4){ref-type="fig"}**), indicating that the catalytic ability of LiGPAT was improved by site-directed mutagenesis. To explore whether this improvement resulted from an increased level of protein expression or an increased enzymatic activity, semi-quantitative analysis of LiGPAT introduced into yeast was performed using western blots with purified LiGPAT polyclonal antibody. The reliability of this antibody was supported by western blot analysis of the total proteins extracted from *L*. *incisa* and transformed *E*. *coli* pmLiG/BL (**Supplementary Figure [S2](#SM3){ref-type="supplementary-material"}**). Comparison of the band intensity on the blots indicated that the expression levels of mLiGPAT and sdmLiGPAT were not significantly difference (*P* \> 0.05) (**Figures [4A,B](#F4){ref-type="fig"}**), suggesting that the site-directed mutagenesis from Arg^195^ to His had no effect on protein expression level but could enhance the enzymatic activity of LiGPAT. This prompted us to investigate the relationship between protein structure and enzymatic activity of LiGPAT because the mutated residue Arg is situated in the G-3-P binding pocket (**Figure [1A](#F1){ref-type="fig"}**).

The crystal structure of squash chloroplastidial GPAT protein (PDB entry 1K30) was the only structure solved with high-resolution that elucidated the structure-function relationship of GPAT ([@B21]; [@B53]; [@B49]). Accordingly, 3D models of mLiGPAT and sdmLiGPAT (**Figure [5](#F5){ref-type="fig"}**) were developed by using the I-TASSER server, which was an integrated platform for automated protein structure and function prediction based on the sequence-to-structure-to-function paradigm ([@B42]). The secondary structural elements of the mLiGPAT and sdmLiGPAT proteins were organized into two domains (**Figure [5A](#F5){ref-type="fig"}**), which were found well conserved in *Cucurbita moschata*, *Chlamydomonas reinhardtii*, *Arabidopsis thaliana*, and *Glycine max* ([@B53]; [@B34]). Domain I is the GPAT_N, and it forms a four-helix bundle (consisting of the 3~10~ helix linking residues 7--10 and helices α1--3) with a simple square, right-handed up--down-up--down topology (**Figures [1A](#F1){ref-type="fig"}** and **[5A](#F5){ref-type="fig"}**). A loop region called the "interlinking loop" linked the small Domain I and the large Domain II. Domain II comprises the alternating α/β secondary structural elements (**Figure [5A](#F5){ref-type="fig"}**) and positively charged residues, which constitutes a positively charged pocket for binding the phosphate group of G-3-P. These residues were well conserved in most plants, except that the His residue at position 195 in mLiGPAT was substituted by Arg (**Figure [1A](#F1){ref-type="fig"}**). However, this replacement did not change the charge property and secondary structure of the pocket from mLiGPAT compared to that from its site-directed mutant sdmLiGPAT (**Figure [5A](#F5){ref-type="fig"}**). Structural superimposition of the binding sites for the phosphate group of G-3-P from mLiGPAT and sdmLiGPAT was illustrated by atom (**Figure [5B](#F5){ref-type="fig"}**) and surface (**Figure [5C](#F5){ref-type="fig"}**). The modeling indicated that the side-chain conformation of residues at positions 195 and 238 were different between these two proteins, suggesting a smaller accessible surface of the phosphate group binding pocket from mLiGPAT than from sdmLiGPAT. Therefore, changes of the side-chain conformation might be responsible for the difference in the enzymatic activity of mLiGPAT and sdmLiGPAT when they function in yeast.

![**Superimposition of 3D structure models of the LiGPAT mature protein (red) and its mutant (Arg195His) (green).** **(A)** Schematic ribbon representation showing the arrangements of α-helices, β-sheets, and loops. Domain I (left) and Domain II (right) are separated by the dashed line. The "interlinking loop" region is indicated by arrow. Residues composing the positively charged G-3-P binding pocket are in yellow. Atom **(B)** and surface **(C)** representation displaying the superimposition of the positively charged G-3-P binding pocket.](fpls-07-00286-g005){#F5}

In brief, acylation by GPAT is considered to be the rate-limiting step in the glycerolipid synthesis pathway and to regulate fatty acid flux through the pathway ([@B11]; [@B57]). In *Arabidopsis*, RNAi of the chloroplastidial *GPAT* in the *ats1-1* mutant background led to small leaves ([@B60]). Thus, it was inferred that the low growth rate of *L*. *incisa* ([@B38]) might be partially associated with the relatively low enzymatic activity of LiGPAT. Recently, a modification of the GPAT-coding gene together with four other genes has been documented to improve the TAG content in *Chlorella minutissima* UTEX 2219 ([@B22]). Hence, genetic manipulation of the G-3-P binding sites of *GPAT* could be taken as a breakthrough to increase the growth rate and glycerolipid content of *L*. *incisa* and other microalgae.
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